Pharmacological interventions for paranoid personality disorder

Birgit A Völlm; Saeed Farooq; Hannah Jones; Michael Ferriter; Simon Gibbon; Jutta Stoffers; Conor Duggan; Nick Huband; Klaus Lieb

doi:10.1002/14651858.CD009100

Pharmacological interventions for paranoid personality disorder

Cochrane Database Syst Rev. 2011:(5):CD009100. doi: 10.1002/14651858.CD009100.

Authors

Birgit A Völlm¹, Saeed Farooq², Hannah Jones³, Michael Ferriter⁴, Simon Gibbon⁵, Jutta Stoffers⁶, Conor Duggan¹, Nick Huband⁷, Klaus Lieb⁸

Affiliations

¹ Forensic Mental Health, Institute of Mental Health, University of Nottingham Innovation Park, Nottingham, UK.
² Postgraduate Medical Institute, Kyber Medical University, Peshawar, Pakistan.
³ Academic Unit of Psychiatry, School of Social and Community Medicine, University of Bristol, Bristol, UK.
⁴ Literature and Evidence Research Unit (LERU), Institute of Mental Health, Nottinghamshire Healthcare NHS Trust, Woodbeck, UK.
⁵ St Andrew's Healthcare, Northampton, UK.
⁶ Department of Psychiatry and Psychotherapy, Freiburg, & Department of Psychiatry and Psychotherapy, Mainz, Germany.
⁷ Section of Forensic Mental Health, Institute of Mental Health, Nottingham, UK.
⁸ Department of Psychiatry and Psychotherapy, University Medical Center Mainz, Mainz, Germany.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the effects of pharmacological interventions for people with paranoid personality disorder (PPD).